Defect type, localization and marker gene expression determines early adverse events of matrix-associated autologous chondrocyte implantation.
Defect type, localization and marker gene expression determines early adverse events of matrix-associated autologous chondrocyte implantation. Injury. 2015 Oct; 46 Suppl 4:S2-9.